PP2B-Aβ Activators
The chemical class of PP2B-Aβ activators encompasses a diverse array of compounds that indirectly influence the activity of the PP2B-Aβ protein complex. These activators work through various biochemical pathways and cellular processes, primarily by modulating the levels and dynamics of intracellular messengers like calcium and cAMP. The indirect activation of PP2B-Aβ by these compounds is indicative of the intricate regulatory networks within cells, where alterations in one pathway or process can have cascading effects on others.
Compounds such as Okadaic Acid and Calyculin A, which inhibit other protein phosphatases, exemplify the concept of indirect activation through compensatory cellular mechanisms. The elevation of cAMP by agents like Forskolin, Rolipram, and IBMX demonstrates another strategy, where the activation of cAMP-dependent pathways can influence the regulation of PP2B-Aβ. The role of calcium signaling is highlighted by compounds such as A23187, Thapsigargin, and Ryanodine, which modulate calcium levels and, in turn, affect calcium-dependent pathways linked to PP2B-Aβ activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin elevates cAMP levels, leading to the activation of PKA. PKA can then influence signaling pathways that intersect with those regulating PP2B-Aβ, potentially enhancing its activity. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
As a selective inhibitor of phosphodiesterase 4 (PDE4), Rolipram increases intracellular cAMP levels, which could indirectly activate PP2B-Aβ through cAMP-dependent pathways. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, raising cAMP and cGMP levels. This increase can modulate various signaling pathways that indirectly activate PP2B-Aβ. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
This cAMP analog mimics the action of cAMP and can activate PKA and other cAMP-dependent pathways, potentially leading to an indirect activation of PP2B-Aβ. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels. Elevated calcium can activate calmodulin-dependent pathways, indirectly influencing PP2B-Aβ activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin elevates intracellular calcium by inhibiting the ER calcium ATPase. This increase in calcium can indirectly enhance PP2B-Aβ activity through calcium-dependent signaling mechanisms. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
BAPTA-AM is a cell-permeable calcium chelator. By modulating intracellular calcium levels, it can influence calcium-dependent pathways that intersect with PP2B-Aβ regulation. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine is a calcium channel blocker. By altering calcium dynamics, it can indirectly modulate pathways that influence PP2B-Aβ activity. | ||||||
Nimodipine | 66085-59-4 | sc-201464 sc-201464A | 100 mg 1 g | $61.00 $307.00 | 2 | |
Similar to Nifedipine, Nimodipine blocks calcium channels, potentially affecting calcium-dependent signaling pathways that regulate PP2B-Aβ. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $223.00 $799.00 | 19 | |
Ryanodine modulates the release of calcium from the sarcoplasmic/endoplasmic reticulum. This modulation can indirectly influence PP2B-Aβ activity via calcium signaling pathw | ||||||